Hill-Rom (NYSE:HRC) Receives Upgrade From Northcoast. Will Other Analysts Follow Suit?


Hill-Rom (NYSE:HRC) Stock Upgrade

Hill-Rom (NYSE:HRC) was raised by Northcoast from a Neutral rating to a solid Buy rating in a note issued to clients on Wednesday, 16 December.

Approximately 463,185 shares of stock traded hands or 13.14% up from the average. Hill-Rom Holdings, Inc. (NYSE:HRC) has declined 6.63% since May 13, 2015 and is downtrending. It has underperformed by 4.01% the S&P500.

The overall sentiment of institutions has decreased to 0.95 in Q2 2015. Its down 0.34, from 1.29 in 2015Q2. The ratio worsened, as 22 institutions have sold all the shares of Hill-Rom Holdings, Inc. that they owned while 88 funds have taken shares off the table. 24 funds have purchased shares for the first time while 81 added to their positions. These institutions now hold 57.84 million shares or 17.88% more than the 49.06 million shares they owned in 2015Q2.

The Fund Krensavage Asset Management Llc currently is holding shares equating to 3.87% of its total portfolio in Hill-Rom Holdings, Inc. representing a total of 205,713 shares. Another fund,Rothschild Capital Partners Llc, is holding a total of 149,750 shares equating to 3.27% of their holdings. Additionally, Bernzott Capital Advisors has a 255,312 share stake in Hill-Rom Holdings, Inc. which represents 3.05% of their total portfolio. The Fund, Copper Rock Capital Partners Llc, based out of Massachusetts, has also built up a stake in the stock, which represents a total of 2.57% of their total portfolio. Finally Southernsun Asset Management Llc, a fund which is based in the state of Tennessee reported a total holdings of 1.91 million shares.

Hill-Rom Holdings, Inc. is a medical technology company. The company has a market cap of $3.10 billion. The Firm partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. It has 58.75 P/E ratio. The Firm operates in three divisions: North America, Surgical and Respiratory Care and International.

According to Zacks Investment Research, “HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.”